200 related articles for article (PubMed ID: 19122354)
1. Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients.
Sahin M; Kebapcilar L; Taslipinar A; Azal O; Ozgurtas T; Corakci A; Akgul EO; Taslipinar MY; Yazici M; Kutlu M
Intern Med; 2009; 48(1):33-9. PubMed ID: 19122354
[TBL] [Abstract][Full Text] [Related]
2. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
3. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients.
Leibowitz G; Tsur A; Chayen SD; Salameh M; Raz I; Cerasi E; Gross DJ
Clin Endocrinol (Oxf); 1996 Jun; 44(6):717-22. PubMed ID: 8759185
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
7. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
Putignano P; Bertolini M; Losa M; Cavagnini F
J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
[TBL] [Abstract][Full Text] [Related]
9. The overnight dexamethasone test is a worthwhile screening procedure.
Cronin C; Igoe D; Duffy MJ; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1990 Jul; 33(1):27-33. PubMed ID: 2401096
[TBL] [Abstract][Full Text] [Related]
10. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome.
Fok AC; Tan KT; Jacob E; Sum CF
Steroids; 1991 Nov; 56(11):549-51. PubMed ID: 1814020
[TBL] [Abstract][Full Text] [Related]
11. Screening for Cushing's syndrome in obese patients.
Tiryakioglu O; Ugurlu S; Yalin S; Yirmibescik S; Caglar E; Yetkin DO; Kadioglu P
Clinics (Sao Paulo); 2010; 65(1):9-13. PubMed ID: 20126340
[TBL] [Abstract][Full Text] [Related]
12. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
Nishida S; Matsumura S; Horino M; Oyama H; Tenku A
Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
[TBL] [Abstract][Full Text] [Related]
13. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome.
Kungpanichkul N
J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407
[TBL] [Abstract][Full Text] [Related]
15. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
16. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
[TBL] [Abstract][Full Text] [Related]
17. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
Esfahanian F; Kazemi R
Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
[TBL] [Abstract][Full Text] [Related]
18. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
19. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
[TBL] [Abstract][Full Text] [Related]
20. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Montwill J; Igoe D; McKenna TJ
Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
